Contracts › 75N95024F00003
75N95024F00003: Kaler to - Viral Gene Therapy for Menkes Disease
Awarded to Battelle Memorial Institute by National Institutes of Health (NIH).
$3.1Mobligated
$6.1Mpotential value
29 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N95024F00003 |
|---|---|
| Vehicle | 75N95022D00021 |
| Awardee | Battelle Memorial Institute |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | MD |
| Offers received | 1 |
| Period of performance | 30 September 2024 to 29 September 2027 |
| Potential end | 29 September 2027 |
| Estimated recompete solicitation | ~Q2 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record